Viracta is focused on advancing a proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr Virus, and will pursue opportunities to address other serious virus-associated disease.
Location: United States, California, Encinitas
Employees: 11-50
Total raised: $68.4M
Founded date: 2007
Investors 3
Date | Name | Website |
07.08.2021 | New Enterp... | nea.com |
24.02.2024 | Aisling Ca... | aislingcap... |
- | aMoon Fund | amoon.fund... |
Funding Rounds 2
Date | Series | Amount | Investors |
05.11.2021 | - | $50M | - |
05.04.2017 | Series B | $18.4M | - |
Mentions in press and media 25
Date | Title | Description | Source |
07.03.2024 | Viracta Therapeutics Reports Fourth Quarter and Full Year 20... | - | globenewsw... |
31.01.2022 | Viracta Therapeutics Announces First Patient Dosed in Phase ... | SAN DIEGO, Jan. 31, 2022 /PRNewswire/ -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision onco... | marketscre... |
29.11.2021 | Viracta Therapeutics Announces Orphan Drug Designation Grant... | SAN DIEGO, Nov. 29, 2021 /PRNewswire/ -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision onco... | marketscre... |
08.11.2021 | Viracta Therapeutics Secures $50 Million Credit Facility fro... | SAN DIEGO - Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company primarily focuse... | marketscre... |
05.11.2021 | Viracta Therapeutics, Inc. Secures $50 Million Credit Facili... | ViractaTherapeutics, Inc. announced that the Company has entered into a loan and security agreement ... | marketscre... |
05.11.2021 | Viracta Therapeutics Secures $50 Million Credit Facility fro... | Viracta Therapeutics Secures $50 Million Credit Facility from Silicon Valley Bank and Oxford Finance... | marketscre... |
05.11.2021 | Viracta Therapeutics Secures $50 Million Credit Facility fro... | SAN DIEGO, Nov. 5, 2021 /PRNewswire/ -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncol... | marketscre... |
16.08.2021 | Viracta Therapeutics Announces the Appointment of Flavia Bor... | prnewswire... | |
21.07.2021 | Viracta Therapeutics : Announces FDA Clearance of IND Applic... | SAN DIEGO, July 21, 2021 /PRNewswire/ -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision onco... | marketscre... |
21.07.2021 | Viracta Therapeutics Announces FDA Clearance of IND Applicat... | prnewswire... |
Show more